Vaso Corporation announced its financial results for Q1 2026, reporting total revenue of $19.4 million, a slight 0.5% decrease compared to the same period last year, mainly due to divesting its healthcare IT service business. Despite the revenue dip, gross profit rose by 1.9% to $11.6 million, and net loss narrowed to $887 thousand from $1.1 million in Q1 2025. The company experienced negative cash flow of $12.6 million due to timing of payments but saw an 11.6% increase in deferred revenue. Vaso remains cautiously optimistic for 2026, expecting stronger performance in later quarters and plans to manage uncertainties prudently.
The FDA has approved Roche's Enspryng (satralizumab) as the first and only at-home subcutaneous treatment for adults with thyroid eye disease (TED). This approval follows positive results from Phase III SatraGO-2 trials showing significant reductions...
U.S. spot Ethereum ETFs experienced $60.22 million in net outflows on October 15, continuing a two-day streak of withdrawals. BlackRock's ETHA and Grayscale's ETHE led the outflows with $44.39 million and $18.28 million respectively, while Fidelity's...
Tesla has rapidly expanded its Cybercab robotaxi fleet in Austin, increasing the number of vehicles more than eight times within a month to over 300. This significant growth suggests Elon Musk's vision for autonomous robotaxis is gaining traction. Th...
Lavazza, operated by Yum China, has opened its fifth store in Hong Kong less than a year after its first, with plans to expand to around 10 stores soon. The brand is introducing its signature Buffalo Milk Latte, a popular drink in Mainland China made...
Emergent Metals Corp. has filed amended and restated financial statements for Q2 2026 to correct accounting and disclosure issues, affecting share capital and comprehensive loss figures but not net loss or assets. The company also provided an update ...
